| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10833009 | Molecular Genetics and Metabolism | 2013 | 7 Pages |
Abstract
The data presented here strongly support glutathione as a “redox blood signature” in mitochondrial disorders and its use as a clinical trial endpoint in the development of mitochondrial disease therapies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Anna Pastore, Sara Petrillo, Giulia Tozzi, Rosalba Carrozzo, Diego Martinelli, Carlo Dionisi-Vici, Gianna Di Giovamberardino, Ferdinando Ceravolo, Matthew B. Klein, Guy Miller, Gregory M. Enns, Enrico Bertini, Fiorella Piemonte,